NLRP3 inflammasome promotes the IL-1β level that, in turn, stimulates the EMT; as a result, this increases the tumor progressionEMT-TFs increased the drug resistance via enhancing the promoter activity of ABC transporters. This evidence concerns the gene ABCG2 and neoplasm.